USANA Health Sciences, Inc.
USNA
$27.27
-$0.28-1.02%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 235.85M | 249.54M | 213.61M | 200.22M | 212.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 235.85M | 249.54M | 213.61M | 200.22M | 212.87M |
| Cost of Revenue | 50.18M | 52.45M | 38.55M | 39.26M | 40.33M |
| Gross Profit | 185.66M | 197.09M | 175.06M | 160.96M | 172.54M |
| SG&A Expenses | 168.95M | 181.42M | 166.85M | 145.36M | 154.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 219.13M | 233.87M | 205.40M | 184.62M | 195.03M |
| Operating Income | 16.72M | 15.67M | 8.21M | 15.60M | 17.84M |
| Income Before Tax | 18.82M | 16.74M | 10.43M | 18.61M | 20.20M |
| Income Tax Expenses | 8.37M | 7.45M | 5.95M | 8.00M | 9.77M |
| Earnings from Continuing Operations | 10.44M | 9.29M | 4.48M | 10.61M | 10.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -789.00K | 112.00K | -30.00K | -- | -- |
| Net Income | 9.66M | 9.40M | 4.45M | 10.61M | 10.43M |
| EBIT | 16.72M | 15.67M | 8.21M | 15.60M | 17.84M |
| EBITDA | 24.46M | 24.01M | 12.21M | 19.17M | 21.65M |
| EPS Basic | 0.52 | 0.49 | 0.23 | 0.56 | 0.55 |
| Normalized Basic EPS | 0.59 | 0.56 | 0.34 | 0.61 | 0.66 |
| EPS Diluted | 0.52 | 0.49 | 0.23 | 0.56 | 0.54 |
| Normalized Diluted EPS | 0.59 | 0.55 | 0.34 | 0.61 | 0.66 |
| Average Basic Shares Outstanding | 18.51M | 19.05M | 19.10M | 19.08M | 19.07M |
| Average Diluted Shares Outstanding | 18.54M | 19.09M | 19.10M | 19.08M | 19.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |